<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2022-2-6-12</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-4805</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Особенности вазоактивной регуляции в ворсинчатом хорионе у женщин с самопроизвольным абортом и активной цитомегаловирусной инфекцией</article-title><trans-title-group xml:lang="en"><trans-title>Features of vasoactive substance regulation in chorionic villi in women with spontaneous abortion and active cytomegalovirus infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0212-0201</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андриевская</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Andrievskaya</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андриевская Ирина Анатольевна – доктор биологических наук, профессор РАН, заведующая лабораторией механизмов этиопатогенеза и восстановительных процессов дыхательной системы при неспецифических заболеваниях легких</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>22, Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">irinaandrievskaja@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1024-1532</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ишутина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ishutina</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ишутина Наталия Александровна – доктор биологических наук, ведущий научный сотрудник, лаборатория механизмов этиопатогенеза и восстановительных процессов дыхательной системы при неспецифических заболеваниях легких</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>22, Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">ishutinana@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8938-3594</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Довжикова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dovzhikova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Довжикова Инна Викторовна – доктор биологических наук, ведущий научный сотрудник, лаборатория механизмов этиопатогенеза и восстановительных процессов дыхательной системы при неспецифических заболеваниях легких</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>22, Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">dov_kova100@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8411-0543</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Приходько</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Prikhodko</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Приходько Николай Геннадьевич – аспирант, лаборатория механизмов этиопатогенеза и восстановительных процессов</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>22, Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">nikprih@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8895-3943</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутепова</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutepova</surname><given-names>O. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кутепова Ольга Леонидовна – кандидат биологических наук, младший научный сотрудник, лаборатория молекулярных и трансляционных исследований</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>22, Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">helga1509_84@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Дальневосточный научный центр физиологии и патологии дыхания (ДНЦ ФПД)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Scientific Center of Physiology and Pathology of Respiration</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>16</day><month>07</month><year>2022</year></pub-date><volume>21</volume><issue>2</issue><fpage>6</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Андриевская И.А., Ишутина Н.А., Довжикова И.В., Приходько Н.Г., Кутепова О.Л., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Андриевская И.А., Ишутина Н.А., Довжикова И.В., Приходько Н.Г., Кутепова О.Л.</copyright-holder><copyright-holder xml:lang="en">Andrievskaya I.A., Ishutina N.A., Dovzhikova I.V., Prikhodko N.G., Kutepova O.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/4805">https://bulletin.ssmu.ru/jour/article/view/4805</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценить содержание растворимого рецептора fms-подобной тирозинкиназы (sFlt1), плацентарного фактора роста (PlGF) и васкулоэндотелиального фактора роста (VEGF-А) в тканевых экстрактах в сопоставлении с гистологией слизистой оболочки матки и ворсинчатого хориона у женщин с самопроизвольным абортом и активной цитомегаловирусной (ЦМВ) инфекцией.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Обследована 81 женщина в период с 7-й по 9-ю нед беременности: 51 ЦМВ-серопозитивная с самопроизвольным абортом и активной инфекцией и 30 серонегативных здоровых женщин с медицинским абортом. В плазме крови определяли иммуноглобулины (Ig) класса М и G к ЦМВ, авидность ЦМВ-IgG; в экстрактах ворсинчатого хориона – sFlt1, PlGF, VEGF-А методом иммуноферментного анализа. В мононуклеарных клетках крови, пробах мочи, ворсинчатом хорионе методом полимеразной цепной реакции в режиме реального времени выявляли ДНК ЦМВ. Проводили гистологическое исследование слизистой оболочки матки и ворсинчатого хориона.</p></sec><sec><title>Результаты</title><p>Результаты. В экстрактах ворсинчатого хориона у женщин с самопроизвольным абортом и активной ЦМВ-инфекцией концентрация sFlt-1 была выше в 3,25 раза (р &lt; 0,001), PlGF и VEGF-А – ниже в 1,31 (р &lt; 0,001) и 2,16 раза (р &lt; 0,001), чем у здоровых женщин. Установлена сильная обратная корреляционная связь между уровнями sFlt-1 и PlGF (r = –0,702; р &lt; 0,001) и VEGF-А (r = –0,858; р &lt; 0,0005), прямая связь – PlGF и VEGF-А (r = 0,860; р &lt; 0,001). По данным гистологического исследования, отмечено отставание в децидуализации и трансформации маточных сосудов, инвазии трофобласта, роста и дифференцировки ворсин, формирования фетальных сосудов.</p></sec><sec><title>Заключение</title><p>Заключение. К механизмам самопроизвольного аборта у женщин с активной ЦМВ-инфекцией можно отнести дисбаланс анти- и проангиогенной регуляции, вызывающий ограничение развития плаценты и маточно-плацентарного кровообращения.</p></sec><sec><title> </title><p> </p></sec></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to assess the levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), and vascular endothelial growth factor A (VEGF-A) in tissue extracts in comparison with the histologic examination of the endometrium and chorionic villi in women with spontaneous abortion and active cytomegalovirus (CMV) infection.</p><sec><title>Materials and methods</title><p>Materials and methods. 81 women at 7–9 weeks of pregnancy were examined: of them, 51 women were CMVseropositive with active infection and after spontaneous abortion, and 30 patients were CMV-seronegative, healthy women after therapeutic abortion. Immunoglobulins (Ig) M and G to CMV and CMV IgG avidity were measured in the blood plasma; sFlt1, PlGF, and VEGF-A were determined in extracts of chorionic villi by enzyme immunoassay. CMV DNA was detected in mononuclear cells of peripheral blood, urine, and chorionic villi by real-time polymerase chain reaction (PCR). A histologic examination of the endometrium and chorionic villi was carried out.</p></sec><sec><title>Results</title><p>Results. In chorionic villus extracts of women with spontaneous abortion and active CMV infection, the concentration of sFlt1 was 3.25 times higher (p &lt; 0.001), and the levels of PlGF and VEGF-A were 1.31 (p &lt; 0.001) and 2.16 times lower (p &lt; 0.001) than in healthy women. A strong negative correlation was established between the levels of sFlt1 and PlGF (r = –0.702; p &lt; 0.001) and VEGF-A (r = –0.858; p &lt; 0.0005), and a positive correlation was revealed between PlGF and VEGF-A levels (r = 0.860; p &lt; 0.001). According to the data of the histologic examination, a lag in decidual transformation of uterine vessels, trophoblast invasion, growth and differentiation of villi, and formation of fetal circulation was detected.</p></sec><sec><title>Conclusion</title><p>Conclusion. The mechanisms of spontaneous abortion in women with active CMV infection include an imbalance of pro- and anti-angiogenic factors, which causes impaired placental development and uteroplacental circulation.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>самопроизвольный аборт</kwd><kwd>цитомегаловирусная инфекция</kwd><kwd>ворсинчатый хорион</kwd><kwd>антиангиогенные факторы</kwd><kwd>вазоактивные факторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pregnancy</kwd><kwd>spontaneous abortion</kwd><kwd>cytomegalovirus infection</kwd><kwd>chorionic villi</kwd><kwd>anti-angiogenic factors</kwd><kwd>vasoactive substances</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Соколов Д.И. Васкулогенез и ангиогенез в плаценте. Журнал акушерства и женских болезней. 2007;56(3):129–133.</mixed-citation><mixed-citation xml:lang="en">Соколов Д.И. Васкулогенез и ангиогенез в плаценте. Журнал акушерства и женских болезней. 2007;56(3):129–133.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Burton G.J., Woods A.W., Jauniaux E., Kingdom J.C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473–482. DOI: 10.1016/j.placenta.2009.02.009.</mixed-citation><mixed-citation xml:lang="en">Burton G.J., Woods A.W., Jauniaux E., Kingdom J.C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473–482. DOI: 10.1016/j.placenta.2009.02.009.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tao L., Suhua C., Juanjuan C., Zongzhi Y., Juan X., Dandan Z. In vitro study on human cytomegalovirus affecting early pregnancy villous EVT’s invasion function. Virol. J. 2011;8:114. DOI: 10.1186/1743-422X-8-114.</mixed-citation><mixed-citation xml:lang="en">Tao L., Suhua C., Juanjuan C., Zongzhi Y., Juan X., Dandan Z. In vitro study on human cytomegalovirus affecting early pregnancy villous EVT’s invasion function. Virol. J. 2011;8:114. DOI: 10.1186/1743-422X-8-114.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Maidji E., Nigro G., Tabata T., McDonagh S., Nozawa N., Shiboski S. et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am. J. Pathol. 2010;177(3):1298–1310. DOI: 10.2353/ajpath.2010.091210.</mixed-citation><mixed-citation xml:lang="en">Maidji E., Nigro G., Tabata T., McDonagh S., Nozawa N., Shiboski S. et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am. J. Pathol. 2010;177(3):1298–1310. DOI: 10.2353/ajpath.2010.091210.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hamilton S.T., Scott G., Naing Z., Iwasenko J., Hall B., Graf N. et al. Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One. 2012;7(12):e52899. DOI: 10.1371/journal.pone.0052899.</mixed-citation><mixed-citation xml:lang="en">Hamilton S.T., Scott G., Naing Z., Iwasenko J., Hall B., Graf N. et al. Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One. 2012;7(12):e52899. DOI: 10.1371/journal.pone.0052899.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chow S.S., Craig M.E., Jacques C.F., Hall B., Catteau J., Munro S.C. et al. Correlates of placental infection with cytomegalovirus, parvovirus B19 or human herpes virus 7. J. Med. Virol. 2006;78(6):747–756. DOI: 10.1002/jmv.20618.</mixed-citation><mixed-citation xml:lang="en">Chow S.S., Craig M.E., Jacques C.F., Hall B., Catteau J., Munro S.C. et al. Correlates of placental infection with cytomegalovirus, parvovirus B19 or human herpes virus 7. J. Med. Virol. 2006;78(6):747–756. DOI: 10.1002/jmv.20618.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chou D., Ma Y., Zhang J., McGrath C., Parry S. Cytomegalovirus infection of trophoblast cells elicits an inflammatory response: a possible mechanism of placental dysfunction. Am. J. Obstet Gynecol. 2006;194(2):535–541. DOI: 10.1016/j.ajog.2005.07.073.</mixed-citation><mixed-citation xml:lang="en">Chou D., Ma Y., Zhang J., McGrath C., Parry S. Cytomegalovirus infection of trophoblast cells elicits an inflammatory response: a possible mechanism of placental dysfunction. Am. J. Obstet Gynecol. 2006;194(2):535–541. DOI: 10.1016/j.ajog.2005.07.073.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Boyle J.J., Weissberg P.L., Bennett M.R. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb. Vasc. Biol. 2003;23(9):1553–1558. DOI: 10.1161/01.ATV.0000086961.44581.B7.</mixed-citation><mixed-citation xml:lang="en">Boyle J.J., Weissberg P.L., Bennett M.R. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb. Vasc. Biol. 2003;23(9):1553–1558. DOI: 10.1161/01.ATV.0000086961.44581.B7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Armaly Z., Jadaon J.E., Jabbour A., Abassi Z.A. Preeclampsia: novel mechanisms and potential therapeutic approaches. Front. Physiol. 2018;9:973. DOI: 10.3389/fphys.2018.00973.</mixed-citation><mixed-citation xml:lang="en">Armaly Z., Jadaon J.E., Jabbour A., Abassi Z.A. Preeclampsia: novel mechanisms and potential therapeutic approaches. Front. Physiol. 2018;9:973. DOI: 10.3389/fphys.2018.00973.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Maidji E., Nigro G., Tabata T., McDonagh S., Nozawa N., Shiboski S. et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am. J. Pathol. 2010;177(3):1298–1310. DOI: 10.2353/ajpath.2010.091210.</mixed-citation><mixed-citation xml:lang="en">Maidji E., Nigro G., Tabata T., McDonagh S., Nozawa N., Shiboski S. et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am. J. Pathol. 2010;177(3):1298–1310. DOI: 10.2353/ajpath.2010.091210.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Волкова Е.В, Джохадзе Л.Я., Лысюк Е.Ю. Изменение уровня ангиогенных факторов у беременных с хронической артериальной гипертензией. Современные технологии в медицине. 2013;5(1):91–96.</mixed-citation><mixed-citation xml:lang="en">Волкова Е.В, Джохадзе Л.Я., Лысюк Е.Ю. Изменение уровня ангиогенных факторов у беременных с хронической артериальной гипертензией. Современные технологии в медицине. 2013;5(1):91–96.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Penka L., Kagan K.O., Hamprecht K. Enhanced serum levels of sFlt1: impact on materno-fetal CMV transmission. J. Clin. Med. 2020;9(5):1258. DOI: 10.3390/jcm9051258.</mixed-citation><mixed-citation xml:lang="en">Penka L., Kagan K.O., Hamprecht K. Enhanced serum levels of sFlt1: impact on materno-fetal CMV transmission. J. Clin. Med. 2020;9(5):1258. DOI: 10.3390/jcm9051258.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Pereira L., Maidji E., McDonagh S., Genbacev O., Fisher S. Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J. Virol. 2003;77(24):13301–13314. DOI: 10.1128/jvi.77.24.13301-13314.2003.</mixed-citation><mixed-citation xml:lang="en">Pereira L., Maidji E., McDonagh S., Genbacev O., Fisher S. Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J. Virol. 2003;77(24):13301–13314. DOI: 10.1128/jvi.77.24.13301-13314.2003.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Andrievskaya I.A., Dovzhikova I.V., Ishutina N.A., Gorikov I.N., Dorofienko N.N., Petrova K.K. et al. Soluble tumor necrosis factor receptor 1 is a potential marker of inflammation in the trophoblast associated with cytomegalovirus infection. Am. J. Respir. Crit. Care Med. 2019;199:A6173. DOI: 10.1164/ajrccm-conference.2019.199.1.</mixed-citation><mixed-citation xml:lang="en">Andrievskaya I.A., Dovzhikova I.V., Ishutina N.A., Gorikov I.N., Dorofienko N.N., Petrova K.K. et al. Soluble tumor necrosis factor receptor 1 is a potential marker of inflammation in the trophoblast associated with cytomegalovirus infection. Am. J. Respir. Crit. Care Med. 2019;199:A6173. DOI: 10.1164/ajrccm-conference.2019.199.1.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ишутина Н.А., Андриевская И.А., Довжикова И.В., Дорофиенко Н.Н., Гориков И.Н. Взаимосвязь окислительного стресса, дисбаланса жирных кислот в реализации апоптоза в плаценте при цитомегаловирусной инфекции в первом триместре. Acta Biomedica Scientifica (East Siberian Biomedical Journal). 2019;4(2):16–22. DOI: 10.29413/ABS.2019-4.2.2.</mixed-citation><mixed-citation xml:lang="en">Ишутина Н.А., Андриевская И.А., Довжикова И.В., Дорофиенко Н.Н., Гориков И.Н. Взаимосвязь окислительного стресса, дисбаланса жирных кислот в реализации апоптоза в плаценте при цитомегаловирусной инфекции в первом триместре. Acta Biomedica Scientifica (East Siberian Biomedical Journal). 2019;4(2):16–22. DOI: 10.29413/ABS.2019-4.2.2.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson L.P., Al-Hasan Y. Impact of oxidative stress in fetal programming. J. Pregnancy. 2012;2012:582748. DOI: 10.1155/2012/582748.</mixed-citation><mixed-citation xml:lang="en">Thompson L.P., Al-Hasan Y. Impact of oxidative stress in fetal programming. J. Pregnancy. 2012;2012:582748. DOI: 10.1155/2012/582748.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rada C.C., Murray G., England S.K. The SK3 channel promotes placental vascularization by enhancing secretion of angiogenic factors. Am. J. Physiol. Endocrinol. Metab. 2014;307(10):E935–E943. DOI: 10.1152/ajpendo.00319.2014.</mixed-citation><mixed-citation xml:lang="en">Rada C.C., Murray G., England S.K. The SK3 channel promotes placental vascularization by enhancing secretion of angiogenic factors. Am. J. Physiol. Endocrinol. Metab. 2014;307(10):E935–E943. DOI: 10.1152/ajpendo.00319.2014.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Maynard S.E., Venkatesha S., Thadhani R., Karumanchi S.A. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr. Res. 2005;57:1R– 7R. DOI: 10.1203/01.PDR.0000159567.85157.B7.</mixed-citation><mixed-citation xml:lang="en">Maynard S.E., Venkatesha S., Thadhani R., Karumanchi S.A. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr. Res. 2005;57:1R– 7R. DOI: 10.1203/01.PDR.0000159567.85157.B7.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bakrania B.A., Spradley F.T., Drummond H.A., LaMarca B., Ryan M.J., Granger J.P. Preeclampsia: linking placental ischemia with maternal endothelial and vascular dysfunction. Compr. Physiol. 2020;11(1):1315–1349. DOI:10.1002/cphy.c200008.</mixed-citation><mixed-citation xml:lang="en">Bakrania B.A., Spradley F.T., Drummond H.A., LaMarca B., Ryan M.J., Granger J.P. Preeclampsia: linking placental ischemia with maternal endothelial and vascular dysfunction. Compr. Physiol. 2020;11(1):1315–1349. DOI:10.1002/cphy.c200008.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Charnock-Jones D.S. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia. J. Reprod. Immunol. 2016;114:81–85. DOI: 10.1016/j.jri.2015.07.004.</mixed-citation><mixed-citation xml:lang="en">Charnock-Jones D.S. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia. J. Reprod. Immunol. 2016;114:81–85. DOI: 10.1016/j.jri.2015.07.004.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gu Y., Lewis D.F., Wang Y. Placental productions and expressions of soluble endoglin, soluble fms‐like tyrosine kinase receptor‐1, and placental growth factor in normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 2008;93(1):260–266. DOI: 10.1210/jc.2007-1550.</mixed-citation><mixed-citation xml:lang="en">Gu Y., Lewis D.F., Wang Y. Placental productions and expressions of soluble endoglin, soluble fms‐like tyrosine kinase receptor‐1, and placental growth factor in normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 2008;93(1):260–266. DOI: 10.1210/jc.2007-1550.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Guo X., Yi H., Li T.C., Wang Y., Wang H., Chen X. Role of vascular endothelial growth factor (VEGF) in human embryo implantation: clinical implications. Biomolecules. 2021;11(2):253. DOI: 10.3390/biom11020253.</mixed-citation><mixed-citation xml:lang="en">Guo X., Yi H., Li T.C., Wang Y., Wang H., Chen X. Role of vascular endothelial growth factor (VEGF) in human embryo implantation: clinical implications. Biomolecules. 2021;11(2):253. DOI: 10.3390/biom11020253.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
